期刊文献+

甲真菌病的外用和联合治疗 被引量:2

Topical and combinant therapy in treatment of onychomycosis
下载PDF
导出
摘要 甲真菌病治疗困难,本文就甲真菌病的外用和联合治疗进行综述。单独外用的药物有28%噻康唑溶液、8%环吡酮甲涂剂和5%阿莫罗芬甲涂剂。化学拨甲也可用于甲真菌病的治疗。对于特殊类型和难治的甲真菌病,联合用药可以提高治愈率,减少药物不良反应的发生。
作者 余进
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2002年第1期57-60,共4页 Journal of Clinical Dermatology
  • 相关文献

参考文献19

  • 1[1]Daniel CR 3rd. Traditional management of onychomycosis[J]. J Am Acad Dermatol,1996,35(3Pt 2):s21- s25.
  • 2[2]Elewski BE. Onychomycosis: pathogenesis,diagnosis,and management[J]. Clin Microbiol Rev,1998,11(3):415- 429.
  • 3[3]Tanuma H. Current topics in diagnosis and treatment of tinea unguium in Japan[J]. J Dermatol,1999,26(2):87- 97.
  • 4[4]Clissold SP, Heel RC. Tioconazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses[J]. Drugs,1986,31(1):29- 51.
  • 5[5]Bohn M, Kraemer KT. Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis[J]. J Am Acad Dermatol,2000,43(4suppl 1):s57- s69.
  • 6[6]Gupta AK, Fleckman P, Baran R. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis[J]. J Am Acad Dermatol,2000,43(4suppl 1):s70- s80.
  • 7[7]Haria M, Bryson HM. Amorolfine.A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections[J]. Drugs,1995,49(1): 103- 120.
  • 8[8]Polak A. Kinetics of amorolfine in human nails[J].Mycoses,1993,36(3- 4):101- 103.
  • 9[9]Reinel D. Topical treatment of onychomycosis with amorolfine 5% nail lacquer: comparative efficacy and tolerability of once and twice weekly use[J]. Dermatology,1992,184(suppl 1):21- 24.
  • 10[10]Lauharanta J.Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly[J]. Clin Exp Dermatol,1992,17(suppl 1):41- 43.

同被引文献17

  • 1虞瑞尧.甲真菌病诊断治疗新进展[J].中国处方药,2005,4(3):60-65. 被引量:7
  • 2白玉明,樊凌雯,褚西宁.真菌可溶性蛋白简易制备方法[J].微生物学通报,1995,22(3):188-191. 被引量:3
  • 3Rosen T. New approache to the diagnosi and management of onychomycosis[J]. Int J Dermatol, 1994,33:292-299.
  • 4Gupta AK,Ryder JE,Summerbell RC.Onychomycosis:classification and diagnosis[J].J Drugs Dermatol,2004,3 (1):51-56.
  • 5Mishra M,Panda P,Tripathy S,et al.An open randomized comparative study of oral itraconazole pulse and terbinafine pulse in the treatment of onychomycosis[J].Indian J Dermatol Venereol Leprol,2005,71 (4):262-266
  • 6Warshaw EM,Fett DD,Bloomfield HE,et al.Pulse versus continuous terbinafine for onychomycosis:a randomized,double-blind,controlled trial[J].J Am Acad Dermatol,2005,53(4):578 -584.
  • 7Darkes MJ,Scott LJ,Goa KL.Terbinafine:a review of its use in onychomycosis in adults[J].Am J Clin Dermatol,2003,4(1):39 -65.
  • 8Arca E,Tastan HB,Akar A,et al.An open,randomized,comparative study of oral fluconazole,itraconazole and terbinafine therapy in onychomycosis[J].J Dermatolog Treat,2002,13(1):3-9.
  • 9Gupta AK.Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States[J].J Am Acad Dermatol,2000,43 (4Suppl):S81 -95
  • 10De Doncker PD,Gupta AK,Marynissen G,Stoffels P,Heremans A.Itraconazole pulse therapy for ony-chomycosis and dermatomycosis:an overview[J].J Am Acad Dermatol,1997,37 (1):969-974.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部